As many biopharma companies have both marketed products and new products in development, an important business need is the periodic (one could argue continuous) evaluation of the value of current and future product portfolios compared to the investment of resources they will require. Current and future market competitiveness on multiple levels needs to be considered when performing this assessment.
Contact Partners in BioPharma Consulting to help you manage and optimize the value of your current and future product portfolios by helping you to identify business strategies that will maximize the current and future value of your product portfolios while minimizing resource investment.
Areas of focus include:
- Development of an optimal portfolio strategy
- Identification of internal and external assets to support the portfolio strategy
- Creation of a portfolio assessment process that includes guidelines for determining the value and selection of development projects that will rationalize and prioritize competing development projects
- Recommendations for life-cycle management and role in portfolio strategies
- Recommendations for partnerships and/or acquisitions in support of the portfolio strategy
